Operating Lease, Right-of-Use Asset in USD of Predictive Oncology Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Predictive Oncology Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Predictive Oncology Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1.63M, a 25.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Predictive Oncology Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.63M -$570K -25.9% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $1.78M -$656K -27% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $1.91M -$669K -25.9% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $2.05M -$496K -19.5% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $2.2M -$666K -23.2% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $2.43M -$576K -19.1% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $2.58M -$480K -15.7% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $2.54M +$2.33M +1100% 31 Dec 2023 8-K 18 Jul 2025
Q3 2023 $2.87M +$2.54M +771% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $3.01M +$2.5M +495% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $3.06M +$2.41M +370% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $212K -$603K -74% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $330K -$632K -65.7% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $506K -$626K -55.3% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $652K -$578K -47% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $814K -$581K -41.6% 31 Dec 2021 10-K 21 Mar 2023
Q3 2021 $961K -$829K -46.3% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $1.13M -$396K -25.9% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $1.23M +$598K +94.8% 31 Mar 2021 10-Q 12 May 2021
Q4 2020 $1.4M +$666K +91.2% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $1.79M +$903K +102% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $1.53M +$523K +52% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $631K +$297K +89.1% 31 Mar 2020 10-Q 08 Jun 2020
Q4 2019 $730K 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $887K 30 Sep 2019 10-Q 15 Nov 2019
Q2 2019 $1.01M 30 Jun 2019 10-Q 19 Aug 2019
Q1 2019 $334K 31 Mar 2019 10-Q 15 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.